S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
S&P 500   3,970.99 (+0.56%)
DOW   32,237.53 (+0.41%)
QQQ   310.89 (+0.37%)
AAPL   160.25 (+0.83%)
MSFT   280.57 (+1.05%)
META   206.01 (+0.85%)
GOOGL   105.44 (-0.15%)
AMZN   98.13 (-0.59%)
TSLA   190.41 (-0.94%)
NVDA   267.79 (-1.52%)
NIO   9.07 (-2.16%)
BABA   86.90 (+0.44%)
AMD   97.95 (-2.32%)
T   18.61 (+0.81%)
F   11.51 (+0.79%)
MU   61.16 (-0.29%)
CGC   1.90 (-0.52%)
GE   91.37 (-0.24%)
DIS   94.08 (-1.83%)
AMC   4.47 (+0.00%)
PFE   40.39 (+0.52%)
PYPL   73.88 (+1.82%)
NFLX   328.39 (+2.50%)
OTCMKTS:ATRX

Adhera Therapeutics - ATRX Stock Forecast, Price & News

$0.55
0.00 (0.00%)
(As of 03/23/2023 12:00 AM ET)
Add
Compare
Today's Range
$0.55
$0.55
50-Day Range
$0.43
$0.95
52-Week Range
$0.43
$3.00
Volume
1 shs
Average Volume
2,908 shs
Market Capitalization
$1.75 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

ATRX stock logo

About Adhera Therapeutics (OTCMKTS:ATRX) Stock

Adhera Therapeutics, Inc. focuses on the discovery and development of drugs. The company was formerly known as Marina Biotech, Inc. and changed its name to Adhera Therapeutics, Inc. in October 2018. Adhera Therapeutics, Inc. is based in Baton Rouge, Louisiana.

Receive ATRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adhera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATRX Stock News Headlines

Adhera Therapeutics, Inc. (ATRX)
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
CGTX Cognition Therapeutics, Inc.
Adhera Therapeutics Announces CEO, Senior...
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
See More Headlines
Receive ATRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Adhera Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

ATRX Company Calendar

Today
3/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:ATRX
Employees
2
Year Founded
N/A

Profitability

Net Income
$-6,350,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
($29.65) per share

Miscellaneous

Free Float
2,283,000
Market Cap
$1.75 million
Optionable
Not Optionable
Beta
-0.07

Key Executives

  • Dr. Zahed Subhan B.S. (Age 64)
    BS, L.L.B., LLB (Law), M.B.A., M.S., MBA, MS, CEO, Chief Scientific Officer & Chairman
    Comp: $8.33k
  • Mr. Andrew Albert Kucharchuk M.B.A. (Age 41)
    Vice Chairman, COO, Acting CFO & Chief Bus. Officer
    Comp: $186k













ATRX Stock - Frequently Asked Questions

How have ATRX shares performed in 2023?

Adhera Therapeutics' stock was trading at $0.82 on January 1st, 2023. Since then, ATRX stock has decreased by 32.9% and is now trading at $0.55.
View the best growth stocks for 2023 here
.

When did Adhera Therapeutics' stock split?

Shares of Adhera Therapeutics reverse split on Thursday, October 6th 2022. The 1-20 reverse split was announced on Thursday, October 6th 2022. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 6th 2022. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

What other stocks do shareholders of Adhera Therapeutics own?
What is Adhera Therapeutics' stock symbol?

Adhera Therapeutics trades on the OTCMKTS under the ticker symbol "ATRX."

How do I buy shares of Adhera Therapeutics?

Shares of ATRX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Adhera Therapeutics' stock price today?

One share of ATRX stock can currently be purchased for approximately $0.55.

How much money does Adhera Therapeutics make?

Adhera Therapeutics (OTCMKTS:ATRX) has a market capitalization of $1.75 million. The company earns $-6,350,000.00 in net income (profit) each year or ($3.57) on an earnings per share basis.

How can I contact Adhera Therapeutics?

Adhera Therapeutics' mailing address is P.O. BOX 2161, WAKE FOREST NC, 27588. The official website for the company is adherathera.com. The company can be reached via phone at 919-518-3748, via email at info@adherathera.com, or via fax at 206-830-9424.

This page (OTCMKTS:ATRX) was last updated on 3/24/2023 by MarketBeat.com Staff